Authors: Nichols, RL Graham, DR Barriere, SL Rodgers, A Wilson, SE Zervos, M Dunn, DL Kreter, B

Citation: Rl. Nichols et al., Treatment of hospitalized patients with complicated Gram-positive skin andskin structure infections - Two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin (Reprinted from The Journal of Antimicrobial Chemotherapy, vol 44, pg 263-273, 1999), FORMULARY, 35, 2000, pp. S36-S47

Authors: Nichols, RL Graham, DR Barriere, SL Rodgers, A Wilson, SE Zervos, M Dunn, DL Kreter, B

Citation: Rl. Nichols et al., Treatment of hospitalized patients with complicated Gram-positive skin andskin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin (vol 44, pg 263, 1999), J ANTIMICRO, 44(4), 1999, pp. 585-585

Authors: Nichols, RL Graham, DR Barriere, SL Rodgers, A Wilson, SE Zervos, M Dunn, DL Kreter, B

Citation: Rl. Nichols et al., Treatment of hospitalized patients with complicated Gram-positive skin andskin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin, J ANTIMICRO, 44(2), 1999, pp. 263-273

Authors: Lee, J Lawrence, BJ Sullivan, SD Johnson, NE Barriere, SL Lake, KD Stevenson, JG

Citation: J. Lee et al., Guidelines for pharmacoeconomic research fellowships, PHARMACOTHE, 19(9), 1999, pp. 1105-1109